513 related articles for article (PubMed ID: 11278247)
1. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
[TBL] [Abstract][Full Text] [Related]
3. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.
Brzovic PS; Keeffe JR; Nishikawa H; Miyamoto K; Fox D; Fukuda M; Ohta T; Klevit R
Proc Natl Acad Sci U S A; 2003 May; 100(10):5646-51. PubMed ID: 12732733
[TBL] [Abstract][Full Text] [Related]
4. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
Baer R; Ludwig T
Curr Opin Genet Dev; 2002 Feb; 12(1):86-91. PubMed ID: 11790560
[TBL] [Abstract][Full Text] [Related]
5. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
6. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1.
Meza JE; Brzovic PS; King MC; Klevit RE
J Biol Chem; 1999 Feb; 274(9):5659-65. PubMed ID: 10026184
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
Dizin E; Irminger-Finger I
Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
Wu-Baer F; Lagrazon K; Yuan W; Baer R
J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
10. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
12. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
Brzovic PS; Rajagopal P; Hoyt DW; King MC; Klevit RE
Nat Struct Biol; 2001 Oct; 8(10):833-7. PubMed ID: 11573085
[TBL] [Abstract][Full Text] [Related]
13. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
[TBL] [Abstract][Full Text] [Related]
14. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer.
Kiewhuo K; Priyadarsinee L; Sarma H; Sastry GN
J Biomol Struct Dyn; 2023; 41(22):12734-12752. PubMed ID: 36775657
[TBL] [Abstract][Full Text] [Related]
16. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
17. BARD1 regulates BRCA1-mediated transactivation of the p21WAF1/CIP1 and Gadd45 promoters.
Fabbro M; Henderson BR
Cancer Lett; 2008 May; 263(2):189-96. PubMed ID: 18243530
[TBL] [Abstract][Full Text] [Related]
18. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
Atipairin A; Canyuk B; Ratanaphan A
Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
20. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]